Activates TrkA neurotrophin receptor signaling cascade. Promotes axon sprouting and Schwann cell proliferation for peripheral nerve repair. Anti-apoptotic in injured neurons via PI3K/Akt pathway. Reduces neuroinflammation post-injury by modulating microglial activation.
Studies have administered: Preclinical animal models; human dosing not established; early research phase
Rodent peripheral nerve crush models: accelerated functional recovery and axon remyelination. Spinal cord contusion models: reduced secondary injury zone. Human research very early stage.
Preclinical profile only; systemic effects not fully characterized; emerging compound class
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on PNF-α (Protective Neuropeptide Fragment) — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat